Suppr超能文献

经导管和血管内支架移植物治疗缩窄相关假性动脉瘤。

Transcatheter and endovascular stent graft management of coarctation-related pseudoaneurysms.

机构信息

Department of Cardiology, The Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, Bristol, UK.

出版信息

Heart. 2013 Sep;99(17):1275-81. doi: 10.1136/heartjnl-2012-303488. Epub 2013 Jul 3.

Abstract

OBJECTIVE

Surgical correction of congenital aortic coarctation can lead to a number of important problems including late pseudoaneurysm formation. Redo surgery has a significant risk. Endovascular stent graft repair is increasingly used but there are limited data regarding this indication. We describe the experience of two UK congenital referral centres.

DESIGN

Retrospective analysis of patients treated with endovascular aortic stent grafting for late pseudoaneurysms.

SETTING

Two UK congenital heart centres, Bristol Heart Institute and Leeds General Infirmary.

PATIENTS

17 patients were treated 2006-2012. This represents all patients treated with this technique.

MAIN OUTCOME MEASURES

Procedural and postprocedure success and complications.

RESULTS

The average time from index repair to endovascular repair of pseudoaneurysm was 24.6 years. The majority (70.6%) had patch aortoplasty as the original surgical procedure and 41.2% were not under follow-up or discharged. Stent grafting procedural success rate was 100%. Median hospital stay postprocedure was 3 days. There was no procedural mortality or immediate complication. There were four minor early and three minor late complications. Imaging follow-up was available for an average of 31.6 months (range 6-65 months). All patients have demonstrated positive remodelling of the pseudoaneurysm with no incidence of continued expansion or stent graft failure up to 5 years following implant.

CONCLUSIONS

Endovascular stent graft treatment of pseudoaneurysms show promising results in a population who have a high risk of surgical re-intervention. Complication rates appear to be low and recovery is quick. Longer-term data remain essential to scrutinise stent graft performance in this situation.

摘要

目的

先天性主动脉缩窄的手术矫正可能会导致许多重要问题,包括晚期假性动脉瘤的形成。再次手术风险很大。血管内支架移植物修复越来越多地被使用,但关于这种适应症的数据有限。我们描述了两个英国先天性转诊中心的经验。

设计

对接受血管内主动脉支架移植物修复晚期假性动脉瘤的患者进行回顾性分析。

地点

英国两个先天性心脏中心,布里斯托尔心脏研究所和利兹综合医院。

患者

17 名患者于 2006 年至 2012 年接受治疗。这代表了所有接受这种技术治疗的患者。

主要观察指标

手术和术后成功率及并发症。

结果

从指数修复到假性动脉瘤血管内修复的平均时间为 24.6 年。大多数(70.6%)的患者最初的手术方法是补片主动脉成形术,41.2%的患者未接受随访或出院。支架移植物的手术成功率为 100%。术后中位住院时间为 3 天。无手术死亡率或即时并发症。有 4 例轻微早期并发症和 3 例轻微晚期并发症。平均有 31.6 个月(6-65 个月)的影像学随访。所有患者均显示假性动脉瘤的积极重塑,在植入后 5 年内无持续扩张或支架移植物失败的发生率。

结论

在手术再干预风险较高的人群中,血管内支架移植物治疗假性动脉瘤显示出良好的效果。并发症发生率似乎较低,恢复较快。仍需要长期数据来仔细检查这种情况下支架移植物的性能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验